Abnormal iron homeostasis and neurodegeneration

Area of Science:

• Neurodegenerative diseases
• Iron metabolism
• Genetics

Background:

• Abnormal iron metabolism is implicated in neurodegeneration.
• Hereditary ferritinopathy (HF) is a rare autosomal dominant disease caused by mutations in the ferritin light chain (FTL) gene.
• HF presents with movement disorders, behavioral changes, and cognitive decline, linked to basal ganglia cavitation and iron deposition.

Purpose of the Study:

• To review the pathogenesis of hereditary ferritinopathy (HF).
• To elucidate the role of ferritin light chain mutations in neurodegeneration.
• To explore potential therapeutic strategies for HF.

Main Methods:

• Review of existing literature on hereditary ferritinopathy.
• Analysis of structural changes in mutant ferritin light chain subunits.
• Examination of a transgenic murine model of HF.

Main Results:

• Mutant FTL subunits assemble into stable ferritin complexes but disrupt iron incorporation.
• Structural alterations lead to iron mishandling, ferritin aggregation, and oxidative damage.
• A murine model recapitulates key features of HF, including neurological deficits and iron dysregulation.

Conclusions:

• HF pathogenesis involves a loss of normal ferritin function and a gain of toxic function.
• Iron accumulation, ferritin aggregation, and oxidative stress are key contributors to neurodegeneration in HF.
• Iron chelators and radical scavengers show potential for clinical investigation in HF treatment.